Cancer is the second leading cause of death worldwide, and it is estimated that Human
papillomavirus (HPV) related cancers account for 5% of all human cancers. Current HPV …

Persistent high‐risk human papillomavirus (HR‐HPV) infection is the strongest risk factor for
high‐grade cervical precancer. We performed a systematic review and meta‐analysis of …

Background The natural history of human papillomavirus (HPV) infections in older women is
critical for preventive strategies, including vaccination and screening intervals, but is poorly …

Human papillomavirus (HPV) is the most common sexually transmitted infection. The effect
of HPV on public health is especially related to the burden of anogenital cancers, most …

The advent of US Food and Drug Administration (FDA)-approved molecular testing for
human papillomavirus (HPV) has resulted in a dramatic shift from cytological testing alone to …

Background Human papillomavirus (HPV) vaccines were designed to prevent cervical
cancer in women and their provision remains a major public health need. However, HPV is …

Understanding the fraction of newly detected human papillomavirus (HPV) infections due to
acquisition and reactivation has important implications on screening strategies and …

Introduction This population-based study aimed to fill the knowledge gap on Human
Papillomavirus (HPV) prevalence and associated sociodemographic risk factors of the …

Background Public awareness of human papillomavirus (HPV) as the causal agent of
cervical cancer and of the availability of HPV vaccines has increased. As a result, more …

Mechanisms for the control and resolution of human papillomavirus (HPV) infection of the
cervix include the local production of cytokines, which control recruitment and function of …